Webcasts

Editors’ Series: Cell and Gene Therapies: Laying the Foundation for a New Supply Chain

Existing biopharma supply chain practices must evolve to meet the needs of personalized therapies, particularly for autologous treatments. Force fitting manual processes will no longer work. Hear about lessons learned in a pioneering “vein to vein” pilot program that aims to establish new rules for data management and exchange, scheduling, and automating workflow and supply chain practices for novel and complex processes. Live: Wednesday, Jul. 29, 2020, at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On Demand: available after airing until Jul. 29, 2021 Register free

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

The complexities of producing cell therapies and gene therapies are testing established biomanufacturing practices and the companies engaged in producing the treatment. Join this webcast to hear about the technical and regulatory hurdles associated with development and manufacturing steps, and strategies and solutions to facilitate development through commercialization. Live: Tuesday, Jul. 28, 2020, at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On Demand: available after airing until Jul. 28, 2021 Register free

Best Practices for Meeting and Exceeding Regulatory Standards in Primary Packaging USP and

Interested in learning more about the regulatory requirements for elastomeric components in parenteral drug packaging? Sign up for the July 22 webcast on “Best Practices for Meeting and Exceeding Regulatory Standards in Primary Packaging USP and ” . This webcast is part of a series focusing on “The Path to Patient Safety – Addressing Industry Concerns and Solutions for Primary Packaging Component Selection.” Live: Part II: Wednesday, Jul. 22, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST On demand available after airing until Jul. 22, 2021 Register free

Effective Imaging for Identification and Sizing API Domains

Combining FTIR and Raman spectroscopy provides the insight needed to ensure appropriate distribution and concentration of APIs within tablets. Watch this webcast to learn more. Live: Tuesday, Jul. 21, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after final airing Jul. 21, 2021 Register free

Expedite Regulated Documents in the Era of COVID-19: From Development to Trials and Manufacturing

Technology is more critical than ever to help you keep your clinical trials on track during the era of COVID-19. Gain best practices about how to empower your remote workforce, get critical regulated documents electronically signed compliantly, and to create a safe and flexible remote patient-centric experience. Live: Wednesday, Jul. 15, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Jul. 15, 2021. Register free

Editors’ Series: Genotoxic Impurities and Drug Quality: Lessons from the Nitrosamine Contamination Crisis

The discovery of nitrosamine-based impurities in APIs has triggered recalls of commonly used drugs and placed the quality of the drug supply in question. Learn best practices for identifying impurities in drug substances and drug products and the roles and responsibilities of ingredients suppliers, drug manufacturers, and regulatory authorities. Live:Tuesday, Jul. 14, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST On Demand: available after airing until Jul. 14, 2021 Register free

How to Choose the Right Approach to Enhance Drug Solubility

What is the correct approach for formulation development of poorly soluble NCEs? Dr. Umesh Barabde, director and operations head, Pharmaceutical Development Services, and Dr. Vishakh Kharat, director, analytical research, Pharmaceutical Development Services, both at Piramal Pharma Solutions discuss classic and specialized techniques to enhance solubility. Live: Thursday, Jun. 25, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after final airing Jun. 25, 2021 Register free

Dry Powder Inhalers: Key Considerations for Combination Product Development

Dry powder inhalers (DPIs) are an important delivery technology for inhaled medicines in both respiratory and non-respiratory disease areas. Andreas Meliniotis, director of device development at Vectura, helps navigate the complex area of DPI product development and highlights the key considerations for both novel- and generic-drug programs. Live: Wednesday, Jun. 24, 2020 at 11am EDT |8am PDT |4pm BST |5pm CEST On demand available after final airing Jun. 24, 2021 Register free

Instrument Systems Take on Burden of Compliance

Want to be sure your systems and processes are compliant? Learn how two enable 21 CFR Part 11 in the lab with compliant workflows and consistent testing. Be confident in your analyses! Live: Tuesday, Jun. 23, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after final airing Jun. 23, 2021 Register free

Specialized Clinical Services for Complex Clinical Studies

This webinar will review Lonza’s integrated clinical supply services inclusive of manufacturing, primary and secondary packaging, kitting, and distribution with special emphasis on complex clinical studies and direct-to-patient shipping. Live: Tuesday, Jun. 23, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Jun. 23, 2021 Register free